HRTX Heron Therapeutics, Inc. - Common Stock
$0,31
Prix · Aoû 19, 2026
Données fondamentales au Aoû 10, 2026
Fourchette 52 semaines
$0–$2
0% of range
Note des analystes
BUY
8 analysts
Objectif de cours
$2
+553% upside
P/E (TTM)
-2.6
ROE
312.5%
Marge nette
-13.0%
HRTX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$0.31
Capitalisation Boursière
$58M
P/E (TTM)
-2.6
BPA (TTM)
$-0.12
Revenus (TTM)
$155M
Rendement div.
—
ROE
312.5%
Dette/Capitaux propres
—
Fourchette 52 semaines
$0 – $2
HRTX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$155M
2016-12-31
→
2025-12-31
BPA
$-0.12
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-28M
2016-12-31
→
2025-12-31
Marges
-13.0%
2023-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
HRTX
Médiane des pairs
P/E (TTM)
-2.6
—
P/S (TTM)
0.4
165.8
P/B
4.0
1.6
Price / FCF (Cours / FCF)
-2.1
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
HRTX
Médiane des pairs
Gross Margin (Marge Brute)
73.3%
71.1%
Operating Margin (Marge d'exploitation)
-1.6%
—
Net Profit Margin (Marge nette)
-13.0%
-2229.6%
ROA
-8.3%
-64.3%
ROE
312.5%
-102.1%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
HRTX
Médiane des pairs
Current Ratio (Ratio de liquidité)
2.5
4.8
Quick Ratio (Ratio de liquidité réduite)
1.2
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
HRTX
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
7.4%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
12.9%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
11.8%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
HRTX
Médiane des pairs
HRTX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
8 analystes
- Achat fort 2 25,0%
- Achat 4 50,0%
- Conserver 2 25,0%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
1 analystes · 2026-08-13
Bas
$2.00
Haut
$2.00
Objectif médian
$2.00
+553,2%
Objectif moyen
$2.00
+553,2%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.01%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.03 | $0.01 | -0.04% |
| 31 mars 2026 | $-0.04 | $-0.02 | -0.02% |
| 31 décembre 2025 | $-0.02 | $-0.02 | 0.00% |
| 30 septembre 2025 | $-0.04 | $-0.02 | -0.02% |
| 30 juin 2025 | $-0.02 | $-0.01 | -0.01% |
| 31 mars 2025 | $0.01 | $-0.01 | 0.02% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Cost of Revenue | $41M | $39M | $65M | $55M | $46M | $36M | $62M | $28M | $5M | $35.0K | |
| Gross Profit | $114M | $106M | $62M | $53M | · | · | · | · | · | · | |
| R&D Expense | $12M | $17M | $39M | $83M | $131M | $175M | $167M | $140M | $139M | $103M | |
| SG&A Expense | $55M | $53M | $66M | $62M | $40M | $42M | $38M | $29M | $26M | $21M | |
| Operating Expenses | $116M | $117M | $173M | $227M | $304M | $317M | $357M | $261M | $225M | $172M | |
| Operating Income | $-3M | $-12M | $-111M | $-175M | $-218M | $-228M | $-211M | $-184M | $-195M | $-171M | |
| Interest Expense | · | · | $4M | $2M | $2M | $2M | $1M | $3M | $4M | $3M | |
| Interest Income | $2M | $4M | $3M | $2M | $433.0K | $4M | $7M | $6M | $1M | $445.0K | |
| Other Non-op | $1M | $430.0K | $560.0K | $-7M | $-878.0K | $-847.0K | $158.0K | $2M | $-38.0K | $-9.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| EPS (Basic) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| EPS (Diluted) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| Shares (Basic) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| Shares (Diluted) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| EBITDA | $-224.0K | $-9M | $-108M | $-172M | $-215M | $-225M | $-209M | $-182M | $-193M | $-171M |
Bilan 23
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $26M | $29M | $15M | $91M | $105M | $72M | $32M | $145M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | $301M | $28M | $38M | |
| Receivables | $90M | $79M | $60M | $52M | $35M | $42M | $40M | $65M | $42M | $2M | |
| Inventory | $93M | $53M | $42M | $55M | $48M | $42M | $25M | $39M | $10M | $5M | |
| Prepaid Expense | $9M | $18M | $6M | $14M | $13M | $22M | $23M | $11M | $4M | $4M | |
| Current Assets | $238M | $209M | $189M | $205M | $254M | $314M | $479M | $447M | $228M | $62M | |
| PP&E (Net) | $12M | $15M | $20M | $22M | $24M | $23M | $20M | $15M | $6M | $5M | |
| PP&E (Gross) | $25M | $33M | $37M | $36M | $37M | $34M | $28M | $23M | $14M | $12M | |
| Accum. Depreciation | $13M | $18M | $17M | $14M | $13M | $11M | $8M | $8M | $8M | $7M | |
| Other Non-current Assets | $5M | $6M | $8M | $16M | $18M | $346.0K | $346.0K | $254.0K | $263.0K | $263.0K | |
| Total Assets | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Accounts Payable | $9M | $12M | $3M | $3M | $4M | $525.0K | $3M | $17M | $19M | $7M | |
| Current Liabilities | $96M | $91M | $80M | $82M | $71M | $103M | $97M | $92M | $103M | $39M | |
| Capital Leases | $0 | · | $3M | $5M | $8M | $15M | $12M | · | · | · | |
| Other Non-current Liabilities | $5M | $615.0K | $241.0K | $241.0K | · | · | · | · | · | · | |
| Total Liabilities | $242M | $267M | $256M | $237M | $228M | $117M | $109M | $92M | $103M | $89M | |
| Common Stock | $2M | $2M | $2M | $1M | $1M | $913.0K | $903.0K | $782.0K | $646.0K | $394.0K | |
| Paid-in Capital | $1.95B | $1.88B | $1.87B | $1.81B | $1.69B | $1.63B | $1.57B | $1.33B | $914M | $564M | |
| Retained Earnings | $-1.94B | $-1.92B | $-1.91B | $-1.80B | $-1.61B | $-1.39B | $-1.17B | $-961M | $-783M | $-586M | |
| AOCI | $4.0K | $13.0K | $13.0K | $-19.0K | $-6.0K | $257.0K | $85.0K | $-87.0K | $-10.0K | $-17.0K | |
| Stockholders' Equity | $14M | $-34M | $-34M | $14M | $78M | $236M | $404M | $370M | $131M | $-21M | |
| Liabilities + Equity | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Shares Outstanding | 188,314,430 | 152,127,878 | 150,285,044 | 119,154,538 | 102,005,000 | 91,310,000 | 90,304,000 | 78,174,000 | 64,609,000 | 39,355 |
Flux de trésorerie 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $10M | $13M | $33M | $43M | $47M | $50M | $51M | $33M | $31M | $26M | |
| Restructuring | · | · | · | · | · | $6M | · | · | · | · | |
| Other Non-cash | $-20M | $-24M | $16M | $-11M | $-33M | $-11M | $27M | $-48M | $-5M | · | |
| Operating Cash Flow | $-28M | $-23M | $-59M | $-147M | $-203M | $-185M | $-125M | $-192M | $-170M | $-134M | |
| CapEx | $317.0K | $2M | $2M | $2M | $3M | $7M | $7M | $9M | $3M | $3M | |
| Investing Cash Flow | $16M | $19M | $18M | $-3M | $33M | $209M | $-22M | $-279M | $8M | $15M | |
| Net Debt Issued | · | · | · | · | · | · | · | $-25M | $-25M | · | |
| Stock Issued | $18M | · | $30M | $75M | · | · | $162M | $363M | $306M | · | |
| Net Stock Activity | $18M | · | $30M | $75M | · | · | $162M | · | · | · | |
| Financing Cash Flow | $14M | $940.0K | $54M | $75M | $156M | $9M | $186M | $358M | $294M | $57M | |
| Net Change in Cash | $3M | $-3M | $13M | $-75M | $-15M | $33M | $40M | $-113M | $131M | $-62M | |
| Free Cash Flow | $-28M | $-24M | $-60M | $-149M | $-206M | $-192M | $-132M | $-201M | $-173M | $-137M |
Rentabilité 6
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.3% | 73.2% | 48.8% | · | · | · | · | · | · | · | |
| Operating Margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% | -257.4% | -144.3% | -237.4% | -632.4% | -13363.2% | |
| Net Margin | -13.0% | -9.4% | -87.0% | -169.0% | -255.6% | -256.4% | -140.3% | -230.8% | -641.9% | -13537.4% | |
| EBITDA Margin | -0.14% | -6.3% | -84.8% | -159.5% | -248.8% | -254.2% | -142.9% | -235.5% | -627.4% | -13363.2% | |
| ROA | -8.3% | -6.0% | -46.7% | -65.4% | -67.0% | -52.5% | -42.0% | -51.3% | -130.9% | -168.7% | |
| ROE | 312.5% | 36.9% | 358.0% | -1010.6% | -224.7% | -88.5% | -59.4% | -46.0% | -359.4% | -357.5% |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 | 3.1 | 5.0 | 4.9 | 2.2 | 1.6 | |
| Quick Ratio | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 | 1.4 | 1.2 | 4.3 | 2.1 | 1.4 | |
| Interest Coverage | · | · | -28.6 | -70.6 | -90.4 | -120.0 | -143.1 | -68.8 | -49.4 | -64.2 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.0 | |
| Inventory Turnover | 0.6 | 0.8 | 1.3 | 1.1 | 1.0 | 1.1 | 1.9 | 1.1 | 0.6 | 0.0 | |
| Receivables Turnover | 1.8 | 2.1 | 2.3 | 2.5 | 2.2 | 2.2 | 2.8 | 1.5 | 1.4 | 1.3 |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.4% | 13.6% | 18.0% | 24.7% | -2.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.9% | 18.7% | 12.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Net Income TTM | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| Market Cap | $245M | $233M | $255M | $298M | $931M | $1.93B | $2.12B | $2.03B | $1M | $516M | |
| P/E | -10.8 | -17.0 | -2.1 | -1.5 | -4.1 | · | · | · | · | · | |
| P/S | 1.6 | 1.6 | 2.0 | 2.8 | 10.8 | 21.8 | 14.5 | 26.2 | 0.0 | 403.1 | |
| P/B | 17.1 | -6.9 | -7.5 | 21.9 | 12.0 | 8.2 | 5.3 | 5.5 | 0.0 | -24.3 | |
| P / Tangible Book | 17.1 | · | · | 21.9 | 12.0 | 8.2 | · | · | · | · | |
| P / Cash Flow | -8.9 | -10.3 | -4.3 | -2.0 | -4.6 | -10.5 | -17.0 | -10.6 | -0.0 | -3.8 | |
| P / FCF | -8.8 | -9.6 | -4.2 | -2.0 | -4.5 | -10.1 | -16.1 | -10.1 | -0.0 | -3.8 | |
| Earnings Yield | -9.2% | -5.9% | -47.1% | -66.8% | -24.5% | · | · | · | · | · |
Compte de résultat 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38M | $35M | $41M | $38M | $37M | $39M | $41M | $33M | $36M | $35M | $34M | $31M | $32M | $30M | $30M | $27M | |
| Cost of Revenue | $12M | $11M | $11M | $12M | $10M | $8M | $10M | $9M | $11M | $8M | $10M | $18M | $20M | $17M | $13M | $15M | |
| Gross Profit | $26M | $24M | $29M | $26M | $27M | $30M | $31M | $23M | $26M | $26M | $24M | $13M | $12M | $13M | $17M | $12M | |
| R&D Expense | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $4M | $5M | $8M | $9M | $13M | $9M | $-14M | $26M | |
| SG&A Expense | $11M | $12M | $13M | $14M | $14M | $13M | $12M | $12M | $14M | $15M | $14M | $16M | $20M | $16M | $34M | $10M | |
| Operating Expenses | $28M | $29M | $29M | $30M | $29M | $27M | $26M | $28M | $32M | $31M | $35M | $38M | $54M | $46M | $10M | $54M | |
| Operating Income | $-2M | $-5M | $38.0K | $-4M | $-2M | $3M | $4M | $-4M | $-6M | $-5M | $-10M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| Other Non-op | $-3M | $-3M | $5M | $-2M | $-744.0K | $-519.0K | $2M | $-390.0K | $-3M | $2M | $0 | $-79.0K | $344.0K | $295.0K | $1M | $-26.0K | |
| Net Income | $-5M | $-8M | $-3M | $-17M | $-2M | $3M | $4M | $-5M | $-9M | $-3M | $-11M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| EPS (Basic) | $-0.03 | $-0.04 | $-0.02 | $-0.10 | $-0.02 | $0.02 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| EPS (Diluted) | $-0.03 | $-0.04 | $-0.01 | $-0.10 | $-0.02 | $0.01 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| Shares (Basic) | 190,335,000 | 189,646,000 | -311,151,000 | 170,348,000 | 154,020,000 | 153,490,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| Shares (Diluted) | 190,335,000 | 189,646,000 | -354,582,000 | 170,348,000 | 154,020,000 | 196,921,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| EBITDA | $-2M | $-4M | · | $-4M | $-2M | $4M | · | $-4M | $-6M | $-4M | · | $-25M | $-42M | $-32M | · | $-42M |
Bilan 22
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $26M | $29M | $43M | $17M | $19M | $26M | $26M | $18M | $20M | · | $35M | $13M | $27M | · | $50M | |
| Receivables | $90M | $84M | $90M | $81M | $80M | $79M | $79M | $67M | $74M | $65M | · | $64M | $77M | $51M | · | $42M | |
| Inventory | $91M | $93M | $93M | $70M | $73M | $57M | $53M | $46M | $43M | $42M | · | $42M | $45M | $52M | · | $52M | |
| Prepaid Expense | $7M | $8M | $9M | $23M | $17M | $26M | $18M | $11M | $7M | $7M | · | $11M | $11M | $15M | · | $8M | |
| Current Assets | $230M | $229M | $238M | $229M | $211M | $213M | $209M | $195M | $191M | $186M | · | $194M | $165M | $178M | · | $224M | |
| PP&E (Net) | $12M | $12M | $12M | $13M | $14M | $15M | $15M | $15M | $16M | $19M | · | $21M | $21M | $22M | · | $23M | |
| PP&E (Gross) | · | · | $25M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $13M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $8M | · | $8M | $9M | $14M | · | $17M | |
| Total Assets | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Accounts Payable | $12M | $9M | $9M | $12M | $12M | $12M | $12M | $10M | $10M | $837.0K | · | $2M | $2M | $4M | · | $7M | |
| Current Liabilities | $92M | $91M | $96M | $90M | $259M | $89M | $91M | $86M | $80M | $75M | · | $80M | $87M | $78M | · | $94M | |
| Capital Leases | $6M | · | · | · | · | · | · | $522.0K | $1M | $2M | · | $4M | $4M | $5M | · | $6M | |
| Other Non-current Liabilities | $5M | $5M | $5M | $5M | $747.0K | $682.0K | $615.0K | $241.0K | $241.0K | $241.0K | · | $241.0K | $241.0K | $241.0K | · | $241.0K | |
| Total Liabilities | $245M | $237M | $242M | $234M | $259M | $264M | $267M | $261M | $256M | $252M | · | $257M | $241M | $232M | · | $250M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $1.96B | $1.95B | $1.95B | $1.94B | $1.89B | $1.89B | $1.88B | $1.88B | $1.88B | $1.87B | · | $1.87B | $1.83B | $1.82B | · | $1.80B | |
| Retained Earnings | $-1.95B | $-1.95B | $-1.94B | $-1.94B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.91B | · | $-1.90B | $-1.87B | $-1.83B | · | $-1.78B | |
| AOCI | $-6.0K | $-6.0K | $4.0K | $0 | $-1.0K | $1.0K | $13.0K | $40.0K | $-8.0K | $-6.0K | · | $-1.0K | $-6.0K | $9.0K | · | $-57.0K | |
| Stockholders' Equity | $7M | $9M | $14M | $15M | $-27M | $-28M | $-34M | $-40M | $-38M | $-34M | $-34M | $-28M | $-39M | $-11M | $14M | $22M | |
| Liabilities + Equity | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Shares Outstanding | · | · | 188,314,430 | · | · | · | 152,127,878 | · | · | · | · | · | · | · | · | · |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $452.0K | $529.0K | $537.0K | $615.0K | $611.0K | $551.0K | $581.0K | $581.0K | $641.0K | $689.0K | $715.0K | $727.0K | $739.0K | $718.0K | $791.0K | $706.0K | |
| Stock-based Comp | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $5M | $3M | $4M | $7M | $14M | $8M | $11M | $11M | |
| Other Non-cash | · | $3M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-797.0K | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-9M | $1M | $-11M | $-9M | $-12M | $3M | $-5M | $-10M | $2M | $-9M | $-27M | $-25M | $-38M | $-37M | |
| CapEx | $138.0K | $391.0K | $0 | $0 | $208.0K | $109.0K | $638.0K | $431.0K | · | · | $250.0K | $793.0K | $278.0K | $224.0K | $414.0K | $45.0K | |
| Investing Cash Flow | $-3M | $-939.0K | $-5M | $12M | $7M | $2M | $11M | $4M | $2M | $1M | $-9M | $-23M | $13M | $37M | $2M | $-36M | |
| Stock Issued | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $82.0K | $-51.0K | $219.0K | $13M | $781.0K | $64.0K | $423.0K | $14.0K | $492.0K | $11.0K | $199.0K | $54M | $319.0K | $-208.0K | $439.0K | $75M | |
| Net Change in Cash | $-5M | $-3M | $-14M | $27M | $-3M | $-7M | $61.0K | $7M | $-2M | $-8M | $-6M | $21M | $-14M | $12M | $-35M | $2M | |
| Free Cash Flow | · | $-2M | · | · | · | $-9M | · | · | · | · | · | · | · | $-25M | · | · |
Rentabilité 6
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.3% | 69.3% | · | 68.8% | 73.5% | 78.3% | · | 71.2% | 70.8% | 75.6% | · | 42.1% | · | · | · | · | |
| Operating Margin | -5.4% | -13.7% | · | -10.7% | -4.4% | 8.1% | · | -13.6% | -17.9% | -13.8% | · | -79.3% | -133.5% | -111.6% | · | -157.7% | |
| Net Margin | -14.6% | -23.4% | · | -45.8% | -6.4% | 6.8% | · | -14.8% | -25.6% | -9.1% | · | -79.6% | -132.4% | -110.7% | · | -157.8% | |
| EBITDA Margin | -5.4% | -12.2% | · | -10.7% | -4.4% | 9.5% | · | -13.6% | -17.9% | -11.8% | · | -79.3% | -133.5% | -109.2% | · | -157.7% | |
| ROA | -2.3% | -3.4% | · | -7.4% | -1.1% | 1.2% | · | -2.1% | -4.4% | -1.4% | · | -10.0% | -18.9% | -13.2% | · | -13.4% | |
| ROE | 53.9% | 84.0% | · | 139.3% | 7.3% | -8.5% | · | 14.3% | 23.9% | 14.0% | · | 937.3% | 137.8% | -523.1% | · | -59.3% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.5 | · | 2.6 | 0.8 | 2.4 | · | 2.3 | 2.4 | 2.5 | · | 2.4 | 1.9 | 2.3 | · | 2.4 | |
| Quick Ratio | 1.2 | 1.2 | · | 1.4 | 0.4 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | 1.0 | 1.0 | · | 1.0 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.3 | · | 0.3 | |
| Receivables Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 |
Valorisation (TTM) 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $148M | $149M | · | $147M | $145M | $142M | · | $135M | $134M | $127M | · | $119M | $116M | $107M | · | $101M | |
| Net Income TTM | $-33M | $-25M | · | $-22M | $-14M | $-15M | · | $-42M | $-79M | $-103M | · | $-142M | $-173M | $-195M | · | $-215M | |
| P/E | -2.3 | -5.3 | · | -9.0 | -20.7 | -22.0 | · | -7.1 | -5.8 | -3.4 | · | -0.9 | -0.7 | -0.8 | · | -2.0 | |
| Earnings Yield | -44.2% | -18.8% | · | -11.1% | -4.8% | -4.5% | · | -14.1% | -17.1% | -29.2% | · | -113.6% | -133.6% | -121.2% | · | -49.0% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $155M | $144M | $127M | $108M | $86M |
| Marge Brute % | 73.3% | 73.2% | 48.8% | — | — |
| Marge d'exploitation % | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% |
| Résultat net | $-20M | $-14M | $-111M | $-182M | $-221M |
| BPA dilué | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 |
| Ratio de liquidité réduite | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-28M | $-24M | $-60M | $-149M | $-206M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 184 déclarants · $51.8M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 25 (-7 vs T. préc.) | 21 (-6 vs T. préc.) | 50 (+3 vs T. préc.) | 40 (-6 vs T. préc.) | -15.3M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Rubric Capital Management LP | $12 823 986 | 30 046 828 | 24,76% | Actions |
| Clearline Capital LP | $4 858 675 | 11 383 961 | 9,38% | Actions |
| Velan Capital Investment Management LP | $3 735 904 | 8 753 290 | 7,21% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 323 230 | 7 782 741 | 6,42% | Actions |
| Tejara Capital Ltd | $2 778 807 | 6 510 795 | 5,36% | Actions |
| TANG CAPITAL MANAGEMENT LLC | $2 667 500 | 6 250 000 | 5,15% | Actions |
| MILLENNIUM MANAGEMENT LLC | $1 737 119 | 4 070 101 | 3,35% | Actions |
| JW Asset Management, LLC | $1 600 958 | 3 751 073 | 3,09% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $1 543 336 | 3 614 773 | 2,98% | Actions |
| VANGUARD GROUP INC | $1 500 729 | 1 154 407 | 2,90% | Actions |
| Stonepine Capital Management, LLC | $1 500 000 | 1 000 000 | 2,90% | Option d'achat |
| STATE STREET CORP | $1 377 948 | 3 228 557 | 2,66% | Actions |
| Pale Fire Capital SE | $1 071 899 | 2 511 478 | 2,07% | Actions |
| Caption Management, LLC | $896 280 | 2 100 000 | 1,73% | Option de vente |
| Congress Park Capital LLC | $860 620 | 2 016 447 | 1,66% | Actions |
| TWO SIGMA ADVISERS, LP | $675 442 | 519 571 | 1,30% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $674 878 | 1 580 510 | 1,30% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $643 145 | 1 506 900 | 1,24% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $582 906 | 1 365 119 | 1,13% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $547 071 | 1 281 796 | 1,06% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $519 613 | 1 217 463 | 1,00% | Actions |
| Qube Research & Technologies Ltd | $435 802 | 1 021 092 | 0,84% | Actions |
| Caption Management, LLC | $426 800 | 1 000 000 | 0,82% | Actions |
| CM Management, LLC | $426 800 | 1 000 000 | 0,82% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $296 270 | 694 165 | 0,57% | Actions |
| ALLIANCEBERNSTEIN L.P. | $239 958 | 299 910 | 0,46% | Actions |
| Stonepine Capital Management, LLC | $209 468 | 490 787 | 0,40% | Actions |
| DIADEMA PARTNERS LP | $195 783 | 458 723 | 0,38% | Actions |
| Xcelsior Advisor Partners LLC | $173 186 | 405 777 | 0,33% | Actions |
| Apeiron RIA LLC | $158 163 | 370 579 | 0,31% | Actions |
| Squarepoint Ops LLC | $137 078 | 321 177 | 0,26% | Actions |
| Integrated Wealth Concepts LLC | $136 107 | 318 903 | 0,26% | Actions |
| Glenmede Investment Management, LP | $132 710 | 105 326 | 0,26% | Actions |
| Richmond Brothers, Inc. | $131 755 | 308 706 | 0,25% | Actions |
| TWO SIGMA INVESTMENTS, LP | $113 663 | 266 314 | 0,22% | Actions |
| MARSHALL WACE, LLP | $105 194 | 244 638 | 0,20% | Actions |
| NEXPOINT ASSET MANAGEMENT, L.P. | $99 359 | 232 800 | 0,19% | Actions |
| FMR LLC | $96 800 | 226 803 | 0,19% | Actions |
| Abel Hall, LLC | $90 987 | 213 185 | 0,18% | Actions |
| CAROLINAS WEALTH CONSULTING LLC | $90 983 | 41 356 | 0,18% | Actions |
| Horan Securities, Inc. | $86 091 | 41 590 | 0,17% | Actions |
| RHUMBLINE ADVISERS | $83 482 | 195 537 | 0,16% | Actions |
| Cutter & CO Brokerage, Inc. | $80 223 | 36 465 | 0,15% | Actions |
| Quinn Opportunity Partners LLC | $74 837 | 175 344 | 0,14% | Actions |
| GOLDMAN SACHS GROUP INC | $74 770 | 175 188 | 0,14% | Actions |
| DLK Investment Management, LLC | $62 615 | 17 890 | 0,12% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $58 500 | 137 067 | 0,11% | Actions |
| Bank of New York Mellon Corp | $54 073 | 126 693 | 0,10% | Actions |
| D. E. Shaw & Co., Inc. | $51 402 | 120 435 | 0,10% | Actions |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $51 341 | 120 293 | 0,10% | Actions |
| Persistent Asset Partners Ltd | $49 974 | 117 090 | 0,10% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48 289 | 112 300 | 0,09% | Option d'achat |
| BANK OF AMERICA CORP /DE/ | $46 165 | 108 369 | 0,09% | Actions |
| Redwood Family Wealth LLC | $45 015 | 105 472 | 0,09% | Actions |
| Biltmore Family Office, LLC | $42 680 | 100 000 | 0,08% | Actions |
| DEUTSCHE BANK AG\ | $41 409 | 96 300 | 0,08% | Actions |
| IEQ CAPITAL, LLC | $41 234 | 96 612 | 0,08% | Actions |
| BARCLAYS PLC | $37 172 | 87 094 | 0,07% | Actions |
| SEARLE & CO. | $36 812 | 86 250 | 0,07% | Actions |
| Vanguard Global Advisers, LLC | $35 764 | 83 756 | 0,07% | Actions |
| BlackRock, Inc. | $35 761 | 83 788 | 0,07% | Actions |
| Russell Investments Group, Ltd. | $34 675 | 81 246 | 0,07% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $31 406 | 73 585 | 0,06% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $29 147 | 68 291 | 0,06% | Actions |
| CITIGROUP INC | $28 050 | 65 721 | 0,05% | Actions |
| Invesco Ltd. | $27 051 | 63 382 | 0,05% | Actions |
| LPL Financial LLC | $26 083 | 61 112 | 0,05% | Actions |
| COMMONWEALTH EQUITY SERVICES, LLC | $25 254 | 59 176 | 0,05% | Actions |
| Anfield Capital Management, LLC | $24 003 | 30 000 | 0,05% | Actions |
| Mariner, LLC | $23 896 | 55 972 | 0,05% | Actions |
| NICOLET ADVISORY SERVICES, LLC | $23 840 | 16 000 | 0,05% | Actions |
| Chicago Partners Investment Group LLC | $23 526 | 51 254 | 0,05% | Actions |
| CWM, LLC | $23 115 | 28 890 | 0,04% | Actions |
| Cerity Partners LLC | $22 473 | 52 654 | 0,04% | Actions |
| CAPTRUST FINANCIAL ADVISORS | $22 000 | 51 547 | 0,04% | Actions |
| RAYMOND JAMES FINANCIAL INC | $20 003 | 46 868 | 0,04% | Actions |
| R Squared Ltd | $19 935 | 46 708 | 0,04% | Actions |
| Centiva Capital, LP | $19 422 | 45 507 | 0,04% | Actions |
| Nuveen Asset Management, LLC | $19 408 | 12 685 | 0,04% | Actions |
| INTECH INVESTMENT MANAGEMENT LLC | $17 990 | 42 150 | 0,03% | Actions |
| HORAN Wealth, LLC | $17 751 | 41 590 | 0,03% | Actions |
| Prospera Financial Services Inc | $17 308 | 40 565 | 0,03% | Actions |
| Cornerstone Select Advisors, LLC | $17 057 | 39 964 | 0,03% | Actions |
| NEUBERGER BERMAN GROUP LLC | $16 647 | 38 987 | 0,03% | Actions |
| Police & Firemen's Retirement System of New Jersey | $16 369 | 38 352 | 0,03% | Actions |
| GROUP ONE TRADING LLC | $16 196 | 37 947 | 0,03% | Actions |
| Creative Planning | $15 306 | 35 862 | 0,03% | Actions |
| Tower Research Capital LLC (TRC) | $15 180 | 35 567 | 0,03% | Actions |
| HSBC HOLDINGS PLC | $14 464 | 33 381 | 0,03% | Actions |
| DDFG, Inc | $14 043 | 32 903 | 0,03% | Actions |
| Concurrent Investment Advisors, LLC | $13 625 | 31 923 | 0,03% | Actions |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $13 425 | 32 397 | 0,03% | Actions |
| CIBC WORLD MARKETS CORP | $13 215 | 10 165 | 0,03% | Actions |
| Skopos Labs, Inc. | $12 744 | 15 927 | 0,02% | Actions |
| CoreCap Advisors, LLC | $12 125 | 28 409 | 0,02% | Actions |
| Vanguard Personalized Indexing Management, LLC | $11 641 | 27 276 | 0,02% | Actions |
| DIVERSIFIED TRUST CO | $11 306 | 26 492 | 0,02% | Actions |
| CITADEL ADVISORS LLC | $11 139 | 26 100 | 0,02% | Option d'achat |
| Pallas Capital Advisors LLC | $10 968 | 25 699 | 0,02% | Actions |
| JANE STREET GROUP, LLC | $10 957 | 25 672 | 0,02% | Actions |
Initiés de la société 39 initiés · 21 dirigeants · 21 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Craig A Collard | Chief Executive Officer | 31 juillet 2026 M | 856 492 | 0 | 0 | $0 |
| Barry D Quart | Chief Executive Officer | 18 janvier 2023 A | 177 989 | 0 | 0 | $0 |
| Ronald J Prentki | President & CEO | 17 février 2010 A | 40 539 | 0 | 0 | $0 |
| Michael Oconnell | Chief Executive Officer | 10 janvier 2006 A | 132 200 | 0 | 0 | $0 |
| Ira Duarte | EVP, Chief Financial Officer | 31 juillet 2026 M | 281 899 | 0 | 0 | $0 |
| Robert Hoffman | CFO & SVP, Finance | 19 décembre 2019 A | 1 280 | 0 | 0 | $0 |
| Brian G. Drazba | VP, Finance & CFO | 31 octobre 2016 J | 3 798 | 0 | 0 | $0 |
| John Whelan | CFO | 18 juillet 2013 M | 254 088 | 0 | 0 | $0 |
| Stephen Whiteford | V.P., Finance & CFO | 15 décembre 2006 A | 15 000 | 0 | 0 | $0 |
| John Poyhonen | President & CCO | 13 avril 2023 M | 46 648 | 0 | 0 | $0 |
| Robert Rosen | President | 15 décembre 2018 A | 2 640 | 0 | 0 | $0 |
| David Leslie Szekeres | EVP, Chief Operating Officer | 13 juillet 2023 M | 33 754 | 0 | 0 | $0 |
| Michael A Adam | Chief Operating Officer | 8 février 2013 A | — | 0 | 0 | $0 |
| William P Forbes | EVP, Chief Development Officer | 31 juillet 2026 M | 241 173 | 0 | 0 | $0 |
| Lisa Peraza | VP, Chief Accounting Officer | 19 janvier 2024 A | 55 907 | 0 | 0 | $0 |
| Kimberly Manhard | EVP, Drug Development | 13 avril 2023 M | 28 330 | 0 | 0 | $0 |
| Marshall Paul | SVP, Technical Operations | 21 mars 2016 M | 2 200 | 0 | 0 | $0 |
| Neil James Clendeninn | SVP & Chief Medical Officer | 12 octobre 2015 A | — | 0 | 0 | $0 |
| Mark S. Gelder MD | SVP & Chief Medical Officer | 12 décembre 2014 A | — | 0 | 0 | $0 |
| John Barr | Vice President of R&D | 8 juillet 2011 A | 51 772 | 0 | 0 | $0 |
| Anastassios D. Retzios | VP of Clinical Development | 15 janvier 2008 A | — | 0 | 0 | $0 |
| Thomas Cusack | Administrateur | 30 janvier 2026 A | 53 960 | 0 | 0 | $0 |
| Morgan Adam | Administrateur | 30 janvier 2026 A | 123 737 | 0 | 0 | $0 |
| Sharmila Dissanaike | Administrateur | 30 janvier 2026 A | 53 960 | 0 | 0 | $0 |
| Michael Kaseta | Administrateur | 30 janvier 2026 A | 53 960 | 0 | 0 | $0 |
| Waage Christian | Administrateur | 30 janvier 2026 A | 53 960 | 0 | 0 | $0 |
| Craig A Johnson | Administrateur | 30 janvier 2026 A | 53 960 | 0 | 0 | $0 |
| Susan Rodriguez | Administrateur | 31 janvier 2025 A | 87 180 | 0 | 0 | $0 |
| Stephen Davis | Administrateur | 16 décembre 2022 A | 52 032 | 0 | 0 | $0 |
| KEVIN TANG | Administrateur | 19 décembre 2019 A | 5 799 810 | 0 | 0 | $0 |
| Greg Turnbull | Administrateur | 29 mai 2012 A | 245 092 | 0 | 0 | $0 |
| Paul Goddard | Administrateur | 29 mai 2012 A | 214 683 | 0 | 0 | $0 |
| Toby Rosenblatt | Administrateur | 20 mai 2010 A | 210 234 | 0 | 0 | $0 |
| Robert L Zerbe MD | Administrateur | 20 mai 2010 A | 202 072 | 0 | 0 | $0 |
| Peter Riepenhausen | Administrateur | 28 mai 2008 A | 9 000 | 0 | 0 | $0 |
| Arthur T Taylor | Administrateur | 28 mai 2008 A | 12 000 | 0 | 0 | $0 |
| Dennis L Winger | Administrateur | 11 août 2006 A | 69 544 | 0 | 0 | $0 |
| Stephen A Drury | Administrateur | 11 août 2006 J | 83 283 | 0 | 0 | $0 |
| Mark Earl Hensley | — | 6 août 2026 M | 170 901 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 3 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Rubric Capital Management LP, David Rosen ×6 dépôts | 17 octobre 2025 | 15,90% | Amendement | — | SEC |
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin Tang ×20 dépôts | 7 janvier 2020 | — | Dépôt initial | — | SEC |
| Felix J. Baker, Julian C. Baker ×3 dépôts | 7 juillet 2011 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 22 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,28% | 128 515 SH | 8 août 2026 | Quotidien |
| IWC · iShares Trust | 0,02% | 537 335 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,01% | 67 617 NS | 30 avril 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 1 328 289 SH | 8 août 2026 | Quotidien |
| ITWO · ProShares Trust | 0,00% | 7 231 NS | 31 mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 198 683 SH | 8 août 2026 | Quotidien |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 869 904 NS | 31 mai 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 3 609 893 SH | 8 août 2026 | Quotidien |
| UWM · ProShares Trust | 0,00% | 5 655 NS | 31 mai 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 505 371 SH | 8 août 2026 | Quotidien |
| URTY · ProShares Trust | 0,00% | 5 714 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 144 NS | 31 mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4 190 NS | 31 mai 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 83 361 NS | 31 mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 28 626 SH | 8 août 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 2 063 361 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5 474 947 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 925 988 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13 208 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 156 616 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12 513 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,00% | 472 185 SH | 8 août 2026 | Quotidien |